11/21
08:28 am
anl
Adlai Nortye to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Adlai Nortye to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/21
08:00 am
anl
Adlai Nortye to Participate in Upcoming Investor Conferences
Medium
Report
Adlai Nortye to Participate in Upcoming Investor Conferences
10/22
12:00 am
anl
Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Low
Report
Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/13
11:19 pm
anl
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
Neutral
Report
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
10/13
11:07 pm
anl
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Neutral
Report
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/3
02:47 pm
anl
Adlai Nortye (NASDAQ:ANL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Adlai Nortye (NASDAQ:ANL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.